“…42 The underlying foundations for this broad recommendation include that central VF loss is common across all stages of glaucoma, [8][9][10][11] that the strong structure/function relationship between 10-2 VF sensitivity and OCT macular structural data can provide diagnostic confirmation of glaucoma, 10,28,[32][33][34][35][36]40 that some eyes with glaucoma demonstrate 10-2 but not 24-2 VF loss, [8][9][10][11][12] that central VF loss is an important consideration in determining treatment intensity, 5,17,18 that central VF loss impacts quality of life, [13][14][15][16] and that the denser testing grid of the 10-2 may improve detection of central VF progression. Despite the potential of 10-2 VF testing, however, it has not yet been shown that 10-2 VF testing is more successful than 24-2 VF testing for detecting the presence of central VF loss, [8][9][10]22,24,25 and this study's findings suggest 10-2 VF loss can be accurately predicted without the employment of 10-2 VF testing. In terms of diagnostic confirmation, it has not been shown that 10-2 VF testing significantly improves the ability to diagnose glaucoma, and only small percentages of patients seem to demonstrate 10-2 VF loss in the absence of 24-2 VF loss.…”